PotentiaMetrics Appointed Marcus Thygeson as CMO

The company named the former Surest executive to lead its clinical strategy and patient advocacy efforts.

Updated on Sept. 22, 2026 in People

Isometric editorial illustration of a medical heart model on a plinth, symbolizing clinical strategy and patient health analytics.
PotentiaMetrics has appointed former Surest executive Marcus Thygeson as Chief Medical Officer to lead the firm's clinical strategy and patient analytics platforms. AI Illustration. Upload story photo >

Live Poll

Do you trust private companies to provide accurate, unbiased information for your healthcare treatment decisions?

PotentiaMetrics has named Marcus Thygeson as its new Chief Medical Officer to oversee clinical strategy and analytics platforms. He succeeds Jerry Henderson, who has transitioned to a new executive role at Beacon Health System.

Why it matters

The company aims to scale its Personalized Shared Decision Making model across the healthcare ecosystem under new clinical leadership. Thygeson will work alongside the advocacy team to provide support for patients navigating complex cancer treatment decisions.

The transition replaces the outgoing Chief Medical Officer with a new hire following an executive search. The appointment marks a singular leadership change at the top of the firm's clinical hierarchy.

The players

Marcus Thygeson

He is a former executive at Surest and Blue Shield of California who holds a medical degree from Harvard Medical School.

Jerry Henderson

He is a former Chief Medical Officer at PotentiaMetrics who recently moved to Beacon Health System as Chief Applications Officer.

PotentiaMetrics

This is a healthcare technology firm focused on scaling clinical decision-making tools for patients.

The details

Marcus Thygeson brings experience from previous roles as Chief Health Officer at Surest and senior executive positions at Blue Shield of California. In his new position, he is tasked with integrating clinical data registries and analytics to enhance patient support resources.

Timeline

  1. PotentiaMetrics announced the leadership change on September 22, 2026.

Market Landscape

The appointment follows Thygeson's involvement with the Quantum Leap Healthcare Collaborative, which focuses on advancing cancer research standards. This leadership shift underscores the company's commitment to integrating high-level clinical governance into its data platform strategy.

Patients and healthcare partners can expect a shift in how clinical data is utilized for decision-making support. These changes are intended to streamline access to information for individuals facing complex cancer diagnosis and treatment choices.

The takeaway

The move signals a heightened focus on data-driven patient advocacy within the clinical tech sector. Patients may see improved resource integration as the company attempts to unify its decision-making tools.

Further reading

For more on industry leadership trends, visit the People section.

Source note: This article includes information reported by Greatreporter -.

Live Poll

Do you trust private companies to provide accurate, unbiased information for your healthcare treatment decisions?